Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Parallel Advisors, LLC ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On June 2, 2026 - Parallel Advisors, LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 12,624 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (NVS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NVS / Novartis AG - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-02 2026-03-31 13F/A-1 NOVARTIS AG ADR ADR 66987V109 0 -12,624 -100.00 0 -100.00
2026-02-11 2025-12-31 13F NOVARTIS AG ADR ADR 66987V109 12,624 148 1.19 1,741 8.75 0.0318
2025-11-13 2025-09-30 13F NOVARTIS AG ADR ADR 66987V109 12,476 351 2.89 1,600 9.07 0.0293
2025-07-08 2025-06-30 13F NOVARTIS AG ADR ADR 66987V109 12,125 -706 -5.50 1,467 2.59 0.0293
2025-04-08 2025-03-31 13F NOVARTIS AG ADR ADR 66987V109 12,831 -1,586 -11.00 1,431 2.00 0.0323
2025-02-10 2024-12-31 13F NOVARTIS AG ADR ADR 66987V109 14,417 496 3.56 1,403 -12.43 0.0316
2024-11-13 2024-09-30 13F NOVARTIS AG ADR ADR 66987V109 13,921 975 7.53 1,601 16.18 0.0376
2024-08-08 2024-06-30 13F NOVARTIS AG ADR ADR 66987V109 12,946 896 7.44 1,378 18.28 0.0353
2024-05-06 2024-03-31 13F NOVARTIS AG ADR ADR 66987V109 12,050 3,179 35.84 1,166 30.17 0.0316
2024-02-12 2023-12-31 13F NOVARTIS AG ADR ADR 66987V109 8,871 -235 -2.58 896 -3.45 0.0266
2024-05-20 2023-09-30 13F/A-1 NOVARTIS AG ADR ADR 66987V109 9,106 298 3.38 928 4.39 0.0309
2023-11-14 2023-09-30 13F NOVARTIS AG ADR ADR 66987V109 9,106 298 928 0.0309
2024-05-20 2023-06-30 13F/A-1 NOVARTIS AG ADR ADR 66987V109 8,808 762 9.47 889 20.00 0.0286
2023-08-04 2023-06-30 13F NOVARTIS AG ADR ADR 66987V109 8,808 762 889 0.0286
2024-05-20 2023-03-31 13F/A-1 NOVARTIS AG ADR ADR 66987V109 8,046 705 9.60 740 11.28 0.0250
2023-04-25 2023-03-31 13F NOVARTIS AG ADR ADR 66987V109 8,046 705 740 0.0250
2023-02-06 2022-12-31 13F NOVARTIS AG ADR ADR 66987V109 7,341 -63 -0.85 666 18.12 0.0289
2022-11-10 2022-09-30 13F NOVARTIS AG ADR ADR 66987V109 7,404 -771 -9.43 563 -18.52 0.0259
2022-08-01 2022-06-30 13F NOVARTIS AG ADR ADR 66987V109 8,175 -2,138 -20.73 691 -23.81 0.0317
2022-04-28 2022-03-31 13F NOVARTIS AG ADR ADR 66987V109 10,313 -1,684 -14.04 907 -13.54 0.0360
2022-01-20 2021-12-31 13F NOVARTIS AG ADR ADR 66987V109 11,997 -1,900 -13.67 1,049 -7.66 0.0389
2021-11-02 2021-09-30 13F/A-1 NOVARTIS AG ADR ADR 66987V109 13,897 2,123 18.03 1,136 5.77 0.0458
2021-08-06 2021-06-30 13F NOVARTIS AG ADR ADR 66987V109 11,774 3,484 42.03 1,074 51.48 0.0455
2021-04-23 2021-03-31 13F NOVARTIS AG ADR ADR 66987V109 8,290 486 6.23 709 -3.80 0.0335
2021-02-02 2020-12-31 13F NOVARTIS AG ADR ADR 66987V109 7,804 157 2.05 737 10.83 0.0400
2020-10-27 2020-09-30 13F NOVARTIS AG ADR ADR 66987V109 7,647 834 12.24 665 11.76 0.0411
2020-07-16 2020-06-30 13F NOVARTIS AG ADR ADR 66987V109 6,813 1,438 26.75 595 34.31 0.0388
2020-04-27 2020-03-31 13F NOVARTIS AG ADR ADR 66987V109 5,375 -1,338 -19.93 443 -30.35 0.0359
2020-01-30 2019-12-31 13F NOVARTIS AG ADR ADR 66987V109 6,713 65 0.98 636 10.03 0.0477
2019-11-01 2019-09-30 13F NOVARTIS AG ADR ADR 66987V109 6,648 1,603 31.77 578 25.38 0.0495
2019-08-05 2019-06-30 13F NOVARTIS AG ADR ADR 66987V109 5,045 105 2.13 461 -2.95 0.0450
2019-05-01 2019-03-31 13F NOVARTIS AG ADR ADR 66987V109 4,940 1,399 39.51 475 56.77 0.0533
2019-02-05 2018-12-31 13F NOVARTIS AG ADR ADR 66987V109 3,541 669 23.29 303 22.67 0.0422
2018-11-01 2018-09-30 13F NOVARTIS AG ADR ADR 66987V109 2,872 58 2.06 247 16.51 0.0307
2018-07-30 2018-06-30 13F NOVARTIS AG ADR ADR 66987V109 2,814 -1,044 -27.06 212 -32.05 0.0303
2018-05-08 2018-03-31 13F NOVARTIS AG ADR ADR 66987V109 3,858 116 3.10 312 -0.64 0.0487
2018-02-13 2017-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 3,742 56 1.52 314 2.95 0.0514
2017-11-15 2017-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR ADR 66987V109 3,686 12 0.33 305 -2.56 0.0525
2017-08-07 2017-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 3,674 458 14.24 313 25.20 0.0590
2017-05-12 2017-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR ADR 66987V109 3,216 -911 -22.07 250 -16.94 0.0497
2017-05-12 2017-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 3,216 250
2017-02-14 2016-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 4,127 4,127 301 0.0707
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F NOVARTIS AG ADR ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F NOVARTIS AG ADR ADR Call 11,774 1,074 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.